• Japanese
  • Korean
  • Chinese
Home > Pharmaceutical > Molecular Targeted Therapeutics Market Research Reports
Category
Pharmaceutical (7248)
Biologics (255)
Biomarker (102)
Cancer (1054)
Clinical Trial (1048)
Diabetes (169)
Drug Delivery System (137)
Drug Discovery (392)
Drug Regulation (101)
Gene Therapeutics & RNAi (102)
Generic Drugs (88)
Genome-based Drug Discovery (143)
Infectious Disease (333)
Molecular Targeted Therapeutics (198)
Neurodegenerative Disease (207)
OTC Drug (88)
Personalized Medicine (58)
Pharmaceutical Companies (1412)
Pipeline Analysis (2191)
Prescription Drugs (520)
Regenerative Medicine (145)
Vaccines (229)

Molecular Targeted Therapeutics Market Research Reports

We offer market research, industry forecasts, and business analysis in the Molecular Targeted Therapeutics as well as other vertical industries. GII sells reports, databases, newsletters and annual information services that provide the latest market data, such as industry forecasts, projections, trends, market shares, research and development, sales and marketing strategies, and competitive analysis.

Filter
Title Search
1 - 25 of 198 Products Sort by Display
*
Product code:298361
Published by BioSeeker Group AB
Published January 12, 2015 Price USD 2999
Content info  
Sample available
Biological Therapies for Cancer: Technologies and Global Markets
Product code:117617
Published by BCC Research
Published January 9, 2015 Price USD 6650
Content info 346 Pages
Sample available
This BCC Research report, Biological Therapies for Cancer: Technologies and Global Markets, provides a detailed overview and thorough analysis of the present and future global market for cancer biotherapeutics....
*
Product code:263237
Published by BioSeeker Group AB
Published January 5, 2015 Price USD 2249
Content info  
Sample available
*
Product code:263210
Published by BioSeeker Group AB
Published January 5, 2015 Price USD 2249
Content info  
Sample available
*
Product code:232971
Published by BioSeeker Group AB
Published January 5, 2015 Price USD 2249
Content info  
Sample available
*
Product code:232970
Published by BioSeeker Group AB
Published January 5, 2015 Price USD 2249
Content info  
Sample available
*
Product code:232969
Published by BioSeeker Group AB
Published January 5, 2015 Price USD 2249
Content info  
Sample available
*
Product code:232968
Published by BioSeeker Group AB
Published January 5, 2015 Price USD 2249
Content info  
Sample available
*
Product code:232962
Published by BioSeeker Group AB
Published January 5, 2015 Price USD 2249
Content info  
Sample available
*
Product code:171794
Published by BioSeeker Group AB
Published January 5, 2015 Price USD 2249
Content info  
Sample available
There are today 67 companies plus partners developing 63 Wnt pathway targeting drugs in 192 developmental projects in cancer....
*
Product code:171793
Published by BioSeeker Group AB
Published January 5, 2015 Price USD 2249
Content info  
Sample available
There are today 139 companies plus partners developing 152 TNF-alpha pathway targeting drugs in 478 developmental projects in cancer....
*
Product code:171792
Published by BioSeeker Group AB
Published January 5, 2015 Price USD 2249
Content info  
Sample available
There are today 163 companies plus partners developing 168 TGF-beta receptor pathway targeting drugs in 394 developmental projects in cancer....
*
Product code:171791
Published by BioSeeker Group AB
Published January 5, 2015 Price USD 2249
Content info  
Sample available
There are today 152 companies plus partners developing 170 T cell receptor pathway targeting drugs in 507 developmental projects in cancer....
*
Product code:171785
Published by BioSeeker Group AB
Published January 5, 2015 Price USD 2249
Content info  
Sample available
Protein kinase inhibitors such as Gleevec, Iressa and Tarceva have allowed the biotechnology industry to deliver on the promise of targeted cancer drugs....
*
Product code:171769
Published by BioSeeker Group AB
Published January 5, 2015 Price USD 2249
Content info  
Sample available
There are today 70 companies plus partners developing 67 Notch pathway targeting drugs in 244 developmental projects in cancer....
*
Product code:171761
Published by BioSeeker Group AB
Published January 5, 2015 Price USD 2249
Content info  
Sample available
The Kit receptor signaling pathway includes activation of PI 3-kinase, Src family kinases and PLC gamma....
*
Product code:171758
Published by BioSeeker Group AB
Published January 5, 2015 Price USD 1499
Content info  
Sample available
The IL-9 signaling pathway activates Jak/STAT and MAPK signaling modules....
*
Product code:171757
Published by BioSeeker Group AB
Published January 5, 2015 Price USD 749
Content info  
Sample available
IL-7 signaling pathway mainly activates the JAK/STAT signaling module....
*
Product code:171756
Published by BioSeeker Group AB
Published January 5, 2015 Price USD 2249
Content info  
Sample available
The IL-6 signaling pathway activates the Jak/STAT, Ras/Raf/MAPK and PI 3-kinase signaling modules....
*
Product code:171755
Published by BioSeeker Group AB
Published January 5, 2015 Price USD 2249
Content info  
Sample available
There are today 108 companies plus partners developing 114 IL-5 pathway targeting drugs in 373 developmental projects in cancer....
*
Product code:171754
Published by BioSeeker Group AB
Published January 5, 2015 Price USD 2249
Content info  
Sample available
The IL-4 signaling pathway stimulates the JAK/STAT and MAPK signaling modules....
*
Product code:171753
Published by BioSeeker Group AB
Published January 5, 2015 Price USD 2249
Content info  
Sample available
The IL-3 signaling pathway activates the JAK/STAT, MAPK and PI 3-kinase signaling modules....
*
Product code:171752
Published by BioSeeker Group AB
Published January 5, 2015 Price USD 2249
Content info  
Sample available
There are today 185 companies plus partners developing 258 IL-2 pathway targeting drugs in 746 developmental projects in cancer....
*
Product code:171751
Published by BioSeeker Group AB
Published January 5, 2015 Price USD 1499
Content info  
Sample available
There are today 53 companies plus partners developing 42 IL-1 pathway targeting drugs in 162 developmental projects in cancer....
*
Product code:171748
Published by BioSeeker Group AB
Published January 5, 2015 Price USD 2249
Content info  
Sample available
There are today 20 companies plus partners developing 20 Hedgehog pathway targeting drugs in 83 developmental projects in cancer....